FAU researchers have discovered that tumour cells can hide from antibody therapy in bone marrow
Scientists from the Division of Genetics at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) in collaboration with Universitätsklinikum Erlangen have made a breakthrough discovery in cancer research.
For the first time, scientists have been able to simulate the complexity of the human immune system and investigate where cancer cells hide when attacked by the immune system. This research is especially relevant for destroying cancer cells through antibody therapy and shows ways that cancer treatment can be improved today. The researchers recently published their findings in the renowned journal Cell Reports.*
Antibodies that are manufactured specifically to fight cancer cells are an essential part of treating breast cancer and lymphoma. They can detect and mark cancer cells in the body so that the malfunctioning cells can be destroyed by the immune system.
However, some cells may survive attacks by the immune system. In the worst case, this can cause tumours to return. 'A key question in cancer therapy is to find out where tumour cells can hide from the immune system,' states Prof. Dr. Falk Nimmerjahn from the Division of Genetics at FAU. 'If we know the answer to this, we can improve current drugs to target where the malformed cells are hiding'.
Two research teams, one from FAU and the other from the Massachusetts Institute of Technology (MIT, Cambridge) (Pallasch et al. Cell), have independently made important breakthroughs in this area. Both research teams were able to show that the effects of antibodies used in human cancer therapy are weakened if tumour cells are found in bone marrow.
'This gives us a unique opportunity to find out how we can improve the antibodies currently used in cancer treatment to remove all tumour cells so that there is actually a chance of curing patients,' says Dr. Anja Lux, research team leader, Division of Genetics, FAU. The significance of these findings is demonstrated by the ability of both research teams to simulate the complexity of the human immune system in their experiments which indicates that the results can be applied to humans with a greater probability.
Further preliminary investigations at MIT lead researchers to believe that a combination of chemotherapy and antibody therapy can lead to greater success in destroying cancer cells in bone marrow. This is an interesting preliminary result which the researchers in Erlangen are intending to take a step further.
'Now that we know where the cancer cells are hiding, we can improve antibody therapy to better activate immune cells in the bone marrow,' explains Prof. Nimmerjahn. This will help to avoid the harmful side effects of chemotherapy, reduce risk for patients and increase chances of curing patients.
*Lux et al., Cell Reports 7, 1-13, 2014; doi:
Pallasch et al., Cell 156, 590-602, 2014
Contact for media:
Prof. Dr. Falk Nimmerjahn
Blandina Mangelkramer | idw - Informationsdienst Wissenschaft
More than just a mechanical barrier – epithelial cells actively combat the flu virus
04.05.2016 | Helmholtz-Zentrum für Infektionsforschung
Discovery of a fundamental limit to the evolution of the genetic code
03.05.2016 | Institute for Research in Biomedicine (IRB Barcelona)
Using an ultra fast-scanning atomic force microscope, a team of researchers from the University of Basel has filmed “living” nuclear pore complexes at work for the first time. Nuclear pores are molecular machines that control the traffic entering or exiting the cell nucleus. In their article published in Nature Nanotechnology, the researchers explain how the passage of unwanted molecules is prevented by rapidly moving molecular “tentacles” inside the pore.
Using high-speed AFM, Roderick Lim, Argovia Professor at the Biozentrum and the Swiss Nanoscience Institute of the University of Basel, has not only directly...
If a person pushes a broken-down car alone, there is a certain effect. If another person helps, the result is the sum of their efforts. If two micro-particles are pushing another microparticle, however, the resulting effect may not necessarily be the sum their efforts. A recent study published in Nature Communications, measured this odd effect that scientists call “many body.”
In the microscopic world, where the modern miniaturized machines at the new frontiers of technology operate, as long as we are in the presence of two...
Researchers from the Max Planck Institute Stuttgart have developed self-propelled tiny ‘microbots’ that can remove lead or organic pollution from contaminated water.
Working with colleagues in Barcelona and Singapore, Samuel Sánchez’s group used graphene oxide to make their microscale motors, which are able to adsorb lead...
Neutron scattering and computational modeling have revealed unique and unexpected behavior of water molecules under extreme confinement that is unmatched by any known gas, liquid or solid states.
In a paper published in Physical Review Letters, researchers at the Department of Energy's Oak Ridge National Laboratory describe a new tunneling state of...
Honeycomb structures as the basic building block for industrial applications presented using holo pyramid
Researchers of the Alfred Wegener Institute (AWI) will introduce their latest developments in the field of bionic lightweight design at Hannover Messe from 25...
27.04.2016 | Event News
15.04.2016 | Event News
12.04.2016 | Event News
04.05.2016 | Physics and Astronomy
04.05.2016 | Physics and Astronomy
04.05.2016 | Materials Sciences